MedTrace Logo

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

NCT04489004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1298

Last updated 2023-02-06

No results posted yet for this study

Summary

This is an open label, multi-center, randomized parallel control clinical trial, to demonstrate the role of driver mechanism in maintenance substrate of persistent atrial fibrillation, and evaluate the clinical outcomes of driver mapping and ablation strategy in patients with persistent atrial fibrillation.

Conditions

  • Atrial Fibrillation, Persistent

Interventions

PROCEDURE

Driver ablation+CPVI

Patients receive driver ablation and CPVI (circumferential pulmonary vein isolation).

PROCEDURE

Stepwise ablation

Patients receive stepwise ablation.

Sponsors & Collaborators

  • Shanghai Chest Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-12-01
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04489004 on ClinicalTrials.gov